Jason Junior

SAN MATEO, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Meru Health, which provides the most comprehensive online mental health solution for depression, burnout and anxiety, announced today that it is providing its online mental health…

A healthier alternative to traditional white rice, brown rice has taken the world by storm. It may look like a typical grain of rice, but its nutrition level is anything but simple. Although both white and brown rice have equal number of…

Issued on: 07/06/2021 - 18:08 The makeshift café terraces that sprang up in Paris last year to serve Covid-wary patrons outdoors will become permanent summer fixtures of the capital,…

The Food and Drug Administration on Monday approved Biogen's Alzheimer's disease drug aducanumab, making it the first medication cleared by U.S. regulators to slow cognitive decline in people living with Alzheimer's and the first new…

High-sensitivity cardiac troponin I (hs-cTnI) assays left much to be desired for their performance among people with kidney impairment in a…

Western countries are moving ahead with the vaccine for children aged 12 to 15 and efforts are being made to go even younger than this age group. Given the vulnerability of children against future waves, countries are planning to…

Autistic people's ability to accurately identify facial expressions is affected by the speed at which the expression is produced and its intensity, according to new research at the University of Birmingham. In particular, autistic people…

When we inhale isolated coronavirus particles, more than 65% reach the deepest region of our lungs where damage to cells can lead to low blood oxygen levels, new research has discovered, and more of these aerosols reach the right lung than…

Pune, India, June 07, 2021 (GLOBE NEWSWIRE) -- Phototherapy Market Overview: The phototherapy market is anticipated to Reach USD 764.55 Million by 2027 recording a 4.61% CAGR in the forecast period. Phototherapy is a kind of medical…

The Food and Drug Administration on Monday approved the first new medication for Alzheimer’s disease in nearly two decades, a contentious decision, made despite opposition from the agency’s independent advisory committee and some…